Developing treatments for rhodopsin-related dominant retinitis pigmentosa
<p>Mutations in the rhodopsin gene are one of the most common causes of autosomal dominant retinitis pigmentosa (ADRP) and there is at present no treatment available. In this thesis, three potential treatments were developed and tested in a R<em>ho</em><sup>P23H/+</sup>...
Autore principale: | Orlans, H |
---|---|
Altri autori: | MacLaren, R |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
2019
|
Soggetti: |
Documenti analoghi
Documenti analoghi
-
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa
di: Abhishek Vats, et al.
Pubblicazione: (2022-05-01) -
TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa
di: Béatrice Bocquet, et al.
Pubblicazione: (2023-11-01) -
Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa
di: David M. Wu, et al.
Pubblicazione: (2021-01-01) -
Adeno-associated virus mediated rhodopsin delivery in preventing secondary cone degeneration in rhodopsin knockout mice
di: Dauletbekov, D
Pubblicazione: (2016) -
Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa
di: Sreelakshmi Vasudevan, et al.
Pubblicazione: (2024-02-01)